0NJP Stock Overview
Engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0NJP from our risk checks.
SOL S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €37.00 |
| 52 Week High | €37.81 |
| 52 Week Low | €25.55 |
| Beta | 0.50 |
| 11 Month Change | 1.23% |
| 3 Month Change | 4.34% |
| 1 Year Change | 32.62% |
| 33 Year Change | 67.04% |
| 5 Year Change | 252.12% |
| Change since IPO | 622.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0NJP | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 6.4% | 0.9% | 1.7% |
| 1Y | 32.6% | -17.6% | 8.3% |
Return vs Industry: 0NJP exceeded the UK Chemicals industry which returned -17.6% over the past year.
Return vs Market: 0NJP exceeded the UK Market which returned 8.3% over the past year.
Price Volatility
| 0NJP volatility | |
|---|---|
| 0NJP Average Weekly Movement | 4.6% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0NJP has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0NJP's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 7,015 | Aldo Romario | www.solgroup.com |
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. The company offers oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use and liquefied natural gas. It also provides oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids.
SOL S.p.A. Fundamentals Summary
| 0NJP fundamental statistics | |
|---|---|
| Market cap | €3.36b |
| Earnings (TTM) | €141.04m |
| Revenue (TTM) | €1.55b |
23.8x
P/E Ratio2.2x
P/S RatioIs 0NJP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0NJP income statement (TTM) | |
|---|---|
| Revenue | €1.55b |
| Cost of Revenue | €1.17b |
| Gross Profit | €375.98m |
| Other Expenses | €234.94m |
| Earnings | €141.04m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.56 |
| Gross Margin | 24.27% |
| Net Profit Margin | 9.10% |
| Debt/Equity Ratio | 55.0% |
How did 0NJP perform over the long term?
See historical performance and comparison